Resource Centre
)
Workflow overview: whole-plasmid sequencing
- Biopharma
- Microbiology
- Infectious disease
- Plasmid
- Bacteria
- DNA
April 10 2025
)
Workflow overview: pharmacogenomics with adaptive sampling
- Biopharma
- Pharmacogenomics
- Human genomics
- Clinical research
- Targeted
- Variant calling
August 5 2025
)
Workflow overview: bacterial isolate sequencing
- Biopharma
- Bacteria
- Whole genome
- DNA
- Microbiology
- Infectious disease
March 18 2025
)
)
)
Using nanopore sequencing for mRNA vaccine quality control: a journey from R&D to GMP
- Biopharma
- Bioinformatics
- GridION
- Transcriptomics
September 18 2024
)
Introductory guide: unlocking the biopharma development pipeline with Oxford Nanopore
- Biopharma
- Direct analysis
- Amplicons
- Plasmid
- mRNA
- AAV
April 16 2025
)
The potential of therapeutic mRNA — and how to measure it
- Biopharma
- Cancer research
- Clinical research
- MinION
- GridION
- Q-Line
September 18 2024
)
The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies
- Biopharma
- Cancer research
- MinION
- Immunology
March 5 2025
)
The art of GMP in the world of NGS: trials, tribulations, and a whole lot of acronyms — a success story
- Biopharma
- Clinical research
- Bioinformatics
- Human genomics
- GridION
- Structural variation
September 18 2024
)
Stepping into the future of nanopore protein sequencing
- Biopharma
- MinION
- GridION
- Multiomics
- Cancer research
- Clinical research
May 19 2025
)
Smarter genomics for streamlined answers — ElysION, sample-to-answer nanopore sequencing device
- Biopharma
- Infectious disease
- Microbiology
- TurBOT
- Metagenomics
September 17 2024
)
Recombinant AAV batch profiling by nanopore sequencing elucidates product-related DNA impurities and vector genome length distribution
- Biopharma
- AAV
- MinION
- Plasmid
January 21 2025
)
Re-adenylation by TENT5A enhances efficacy of SARS-CoV-2 mRNA vaccines
- Biopharma
- mRNA
- Virus
- Infectious disease
April 16 2025
)
rAAV genome sequencing uncovers transgene integrity and packaging impurities
- Biopharma
- AAV
- Infectious disease
May 13 2024
)
Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario
- Biopharma
- Plasmid
- mRNA
- Flongle
September 6 2025
)
Quality control of gene therapy vectors using nanopore direct RNA sequencing
- Biopharma
- Bioinformatics
- Isoforms
- Transcriptomics
- London Calling
May 24 2024
)
Quality control for adeno-associated virus genome preparations using nanopore sequencing
- Biopharma
- AAV
- Microbiology
- Clinical research
May 8 2024
)
Precision cell engineering enabled through nanopore sequencing
- Biopharma
- Bioinformatics
- PromethION 2
- Assembly
- Epigenetics
- Gene expression
September 18 2024
